Daily Morning Note
21 April 2023
Sensex
Current
Value
59,632
Nifty
17,624
0.0
-2.7
Wall Street overnight and investors factoring the data that showed Japan’s
BSE Midcap
24,935
-0.0
-1.5
core inflation for Mar’23 at 3.1%, unchanged from Feb’23. Nikkei is trading
BSE Small cap
28,310
0.1
-2.1
lower by 0.07%, Hang Seng is trading lower by 0.36%, and Shanghai is trading
SGX Nifty Fut.
17,680
-0.02
NA
Indices
%
1D
0.1
%
YTD
-2.0
Sectors – Performance (BSE)
Telecom
1,523
0.8
-12.1
Power
3,630
0.7
-17.1
Capital Goods
35,388
0.6
6.1
Healthcare
22,788
-0.8
-1.1
Realty
3,462
-0.5
0.4
Metal
20,046
-0.4
-3.9
Nifty
Gainers/Losers
CMP
% Chg
TATAMOTORS
477
1.6
NTPC
170
1.6
ASIANPAINT
2,844
1.2
DIVISLAB
3,203
(4.2)
HINDUNILVR
2,493
(1.5)
EICHERMOT
3,247
(1.3)
Market Commentary

Asian Markets: The Asian markets are trading lower tracking weak cues from
lower by 0.21%.

Indian Indices: The Indian Indices are expected to open on a flat note. Sgx
Nifty is currently trading flat.

US Markets: The US Markets ended lower as investors digested disappointing
earnings from major companies like Tesla, AT&T, and America Express. The
Dow Jones lost 110 points or 0.33% to close at 33, 786. The Nasdaq lost 98
points or 0.80% to 12,060.
Q4FY23 Results



Result Update: HCL Technologies (HOLD), Cyient (BUY)
Result Preview (coverage): ICICI Bank
Results on 21 & 22 (non-coverage): Reliance Industries, Hindustan Zinc,
Tejas Networks, Rajratan Global Wire, Wendt (India), Macrotech Developers,
CE Infosystems, Star Housing Finance, and Nath Bio-Genes (India), Yes
Bank
News in Focus
FII Trading activities in Cash
Date
Net
MTD
FII
20-Apr-23
833
722
DII
20-Apr-23
-1,169
-1,182

Siemens: As part of a consortium along with Rail Vikas Nigam, has received
two separate orders from Gujarat Metro Rail Corporation (GMRCL). Siemens'
share in orders is Rs 678 Cr.
Figs. in Rs Cr.

Suven Pharmaceuticals: The Competition Commission of India has approved
Global Indices
Current
Value
%
1D
%
YTD
Dow Jones
33,787
(0.3)
1.9
Pharmaceuticals by Berhyanda Ltd. Berhyanda is ultimately managed by
NASDAQ
12,060
(0.8)
15.2
Advent International Corporation.
DAX
15,796
(0.6)
12.3
Nikkei 225
28,645
0.0
9.8
FTSE 100
7,903
0.1
4.5
Hang Seng
20,349
(0.2)
1.0
Shanghai A Sha
3,367
(0.0)
8.0
the acquisition of up to 76.10% of the voting share capital of Suven

Laxmi Organic Industries announced that the board has approved the
borrowing of funds up to Rs 2,000 Cr.

Finolex Cables will set up a plant at the Urse facility in Pune to produce optical
fibre preforms as well as expand on its fibre draw capacity. The company will
incur a Capex of Rs 290 Cr and the plan will have an initial capacity of 00 tons
Source: Bloomberg; As on 7:30 am IST
of performs.
Forex Rate
INR/USD
82.2
0.1
0.7
INR/EUR
90.1
-0.2
-2.1
INR/GBP
102.1
-0.0
-2.5
INR/YEN (100)
61.0
0.3
2.9

India Grid Trust: International Finance Corporation subscribed to a listed NCD
issuance of the company worth Rs 1,140 Cr.

Greenpanel Industries resumed manufacturing operations at the MDF plant in
Rudrapur, Uttarakhand on April 19. The plant was closed on April 1 for routine
maintenance.
For private circulation only
1
HCL Tech Q4 FY23 Result Update; BUY; TP: 1,245
A Mixed Bag Results; Descent Growth; Better guidance
Est. Vs. Actual for Q3FY23: Revenue – MISS; EBITDA Margin – MISS; PAT – MISS; Deal Wins – BEAT
Revision in Estimates post Q4FY23
FY24E/FY25E: Revenue 9%/14%; EBITDA Margins 21.2%/22%; PAT 9%/14%
Recommendation Rationale
 Improved outlook on the vertical and engagement with clients give us confidence in the company’s growth prospects for the
coming quarters as compared to its Indian peers.
 The company’s TCV stood strong in Q4FY23 with strong with deal wins at $ 2.1 Bn
 The management is confident of gaining medium-term demand momentum on the backdrop of the deals it has won in the previous
quarters along with improving its margin front.
Sector Outlook: Cautiously positive
Company Outlook & Guidance: Revenue is expected to be between 6%–8% YoY in CC. Services Revenue is expected to be
between 6.5%-8.5% YoY (in CC). EBIT margin guidance narrowed to 18.0%–19%
Current Valuation: 17x FY25E P/E;
Earlier Valuation: 17x FY24E
Current TP: 1,245 (Earlier TP: Rs 1245/share)
Recommendation: With global uncertainty and delaying spending decisions, we believe HCL tech to perform better in challenging
times. Supply-side constraints will take some more time to ease off some pressures on operating time. Hence, we recommend a BUY
rating on the stock.
Cyient - Q4FY23 Result Update; BUY: TP: 1,260/share
Strong Recovery; Improved Vertical Outlook
Est. Vs. Actual for Q4FY23: Revenue – BEAT; EBITDA Margin – BEAT; PAT – BEAT; Deal Wins – BEAT
Revision in Estimates post Q4FY23
FY24E/FY25E: Revenue Growth: 15%/15%; EBITDA Margins: 18%/19%; PAT Growth : 16%/17%
Recommendation Rationale
 Improved outlook on the vertical along with deepened engagement with clients boosts our confidence in the future growth
prospects of the company in the forthcoming quarters.
 TCV stood strong in Q4FY23 at $212.7 Mn, implying steady order intake even amidst challenging times.
 The management is confident of gaining medium-term demand momentum along with margin improvement on the backdrop of
the deals the company has won in the previous quarters
Sector Outlook: Cautiously positive
Company Outlook & Guidance: Cyient has given guidance of 15-20% revenue growth in FY24 (in constant currency), aided
by robust client additions. EBIT margins to improve by 100-200bps in FY24.
Current Valuation: 16x FY25E P/E; Earlier Valuation: 15x FY24E
Current TP: 1,260/share (Earlier TP: Rs 1,050/share)
Recommendation: With strong growth potential backed by robust deal wins and superior execution capabilities, we upgrade our
recommendation on the stock to BUY.
For private circulation only
2
Q4FY23 Earnings preview: Our Coverage
Year-end
March
(Rs Cr)
Q4FY23E Q3FY23
QoQ
YoY
Result expectations
Q4FY22
(%)
(%)
 Advances growth to sustain, expected to clock growth of
ICICI Bank
NII
17,233
16,465
4.7%
12,605
36.7%
Non-Interest
Income
5,155
5,024
2.6%
4,737
8.8%
PPOP
13,901
13,271
4.7%
10,293
35.1%
Provision
2,250
2,257
-0.3%
1,069
110.5%
Net Profit
8,714
8,312
4.8%
7,019
24.2%
~20% YoY
 Scope for margin expansion limited, Expect QoQ flat
margins
 Credit costs expected to remain flat QoQ, aiding
profitability
 Moderation in slippages along with higher recoveries to
aid asset quality improvement
EPS
12.5
11.9
4.8%
10.1
23.7%
 Key monitorables: (1) NIM outlook (2) Comments on
Deposit accretion
Note: Showcasing the Earnings preview (expectations) for the companies under our coverage whose results are expected by today or by
tomorrow (If weekend or Holiday)
For private circulation only
3
For private circulation only
4
Investment Picks
Company
Recommendation
CMP
Target
Price
%
Upside
Aarti Drugs Ltd
BUY
427
490
14.8
ACC Ltd
BUY
1,738
2,450
41.0
Aditya Birla Fashion & Retail Ltd
BUY
223
325
45.5
Affle India Ltd
BUY
909
1,350
48.6
Ahluwalia Contracts (India) Ltd
BUY
523
610
16.6
Amber Enterprises India Ltd
BUY
1,853
2,580
39.3
Ambuja Cements Ltd
BUY
381
460
20.8
Aptus Value Housing Finance India Ltd
BUY
255
360
41.1
Ashok Leyland Ltd
BUY
139
175
26.0
Asian Paints Ltd
BUY
2,844
3,200
12.5
Astral Ltd
BUY
1,419
1,725
21.6
AU Small Finance Bank Ltd
BUY
679
755
11.1
Bajaj Finance Ltd
BUY
5,913
7,400
25.2
Bandhan Bank Ltd
BUY
218
275
26.2
Bata India Ltd
BUY
1,459
1,650
13.1
Bharti Airtel Ltd
BUY
772
960
24.3
Birla Corporation Ltd
BUY
906
1,025
13.2
Britannia Industries Ltd
BUY
4,256
5,100
19.8
Can Fin Homes Ltd
BUY
565
650
15.1
CCL Products (India) Ltd
BUY
557
650
16.8
Cipla Ltd
BUY
904
1,300
43.8
City Union Bank Ltd
BUY
133
190
42.6
Coforge Ltd
BUY
3,813
4,715
23.6
CreditAccess Grameen Ltd
BUY
992
1,215
22.4
Dabur India Ltd
BUY
525
650
23.7
DCB Bank Ltd
BUY
102
150
47.3
Dixon Technologies (India) Ltd
BUY
2,988
4,285
43.4
Embassy Office Parks REIT
BUY
322
386
20.0
Equitas Small Finance Bank Ltd
BUY
70
78
12.1
Escorts Kubota Ltd
BUY
1,982
2,200
11.0
Federal Bank Ltd
BUY
132
170
28.5
G R Infraprojects Ltd
BUY
989
1,550
56.8
HCL Technologies Ltd
BUY
1,038
1,245
20.0
HDFC Bank Ltd
BUY
1,672
1,975
18.1
HealthCare Global Enterprises Ltd
BUY
262
330
25.7
Hindustan Unilever Ltd
BUY
2,493
3,000
20.4
ICICI Bank Ltd
BUY
894
1,150
28.6
ICICI Securities Ltd
BUY
440
550
25.0
IDFC First Bank Ltd
BUY
56
75
33.0
Indian Hotels Company Ltd
BUY
335
370
10.4
For private circulation only
5
Investment Picks
Company
ITC Ltd
Karnataka Bank Ltd
KNR Constructions
Kotak Mahindra Bank Ltd
Krishna Institute of Medical Sciences Ltd
L&T Technology Services Ltd
LTIMindtree Ltd
Mahindra CIE Automotive
Manappuram Finance Ltd
Maruti Suzuki India Ltd
MAS Financial Services Ltd
Nippon Life India Asset Management Ltd
Oriental Carbon & Chemicals Ltd
P I Industries Ltd
PNC Infratech Ltd
Praj Industries Ltd
PSP Projects Ltd
Rites Ltd
SBI Cards & Payment Services Ltd
SBI Life Insurance Company Ltd
Shree Cement Ltd
SIS Ltd
Star Cement Ltd
State Bank of India
Steel Authority Of India Ltd
Sundaram Finance Ltd
Symphony Ltd
Tech Mahindra Ltd
Trent Ltd
Ujjivan Small Finance Bank Ltd
UNO Minda Industries Ltd
V I P Industries Ltd
V Mart Retail Ltd
Westlife Foodworld Ltd
For private circulation only
Recommendation
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
BUY
CMP
Target
Price
%
Upside
400
130
235
1,884
1,515
3,360
4,153
370
129
8,715
709
236
727
3,160
277
350
668
351
754
1,129
24,254
376
112
545
83
2,320
995
1,022
1,394
27
505
589
2,199
683
460
170
310
2,330
1,670
4,090
4,950
475
165
9,760
950
345
950
3,830
390
550
800
410
885
1,565
26,700
425
125
750
93
2,605
1,430
1,300
1,700
37
570
850
3,300
930
14.9
30.5
32.2
23.7
10.2
21.7
19.2
28.4
28.1
12.0
34.0
46.4
30.7
21.2
40.8
57.0
19.8
16.9
17.4
38.6
10.1
13.2
11.4
37.7
11.8
12.3
43.7
27.2
22.0
37.8
12.8
44.3
50.1
36.3
6
Index
CMP
Nifty
17,624.45
Sensex
Bank Nifty
% Chng
S2
S1
P
R1
R2
0.03%
17530
17580
17630
17680
17730
59,632.35
0.11%
59305
59470
59655
59815
60000
42,269.50
0.27%
41985
42125
42250
42395
42520
Nifty opened on a flat note and remained in a small range throughout the day. On 20 th April, Nifty closed at 17624 with a gain of 6
points.
On the daily chart index has formed a bearish candle however it remained restricted within past three session's High-Low range
indicating absence of strength on either side. The index continues to move in a Higher Top and Higher Bottom formation on the
hourly chart indicating positive bias. The chart pattern suggests that if Nifty crosses and sustains above 17700 level it would
witness buying which would lead the index towards 17800-17900 levels. Important Support for the day is around 17550 However
if index sustains below 17550 then it may witness profit booking which would take the index towards 17500-17400 levels. Nifty is
trading above 20, 50 and 200 day SMA indicating positive bias in the short to medium term. Nifty continues to remain in an
uptrend for the short term, so buying on dips continues to be our preferred strategy.
The daily strength indicator RSI continues to remain flat and is below its reference line indicating absence of momentum on either
side
The trend deciding level for the day is 17630. If NIFTY trades above this level then we may witness a further rally up to 1768017730-17780 levels. However, if NIFTY trades below 17630 levels then we may see some profit booking initiating in the market,
which may correct up to 17580-17530-17480 levels
STOCK IDEAS FOR THE DAY
Company Name
Buy / Sell
Range
Stop Loss
Target
DELTACORP
Buy above
195
193
197-199
BDL
Buy above
990
980
1000-1010
Note- Stocks Ideas are based on previous day’s close and are activated only if they trade in buy/sell range.
For private circulation only
7
Corporate Action Tracker
Dividend (BSE 500 universe)
Security Code
Security Name
Purpose
Ex-Date
Record Date
Dividend Per
Share
539871
Thyrocare Technologies Ltd
Interim Dividend
20-Apr-23
20-Apr-23
18
500125
E.I.D.-PARRY (INDIA) LTD.
Interim Dividend
21-Apr-23
21-Apr-23
4
500790
NESTLE INDIA LTD.
Final Dividend
21-Apr-23
21-Apr-23
75
500790
NESTLE INDIA LTD.
Interim Dividend
21-Apr-23
21-Apr-23
27
500002
ABB India Limited
Dividend
27-Apr-23
-
5.5
532281
HCL TECHNOLOGIES LTD.
Interim Dividend
28-Apr-23
28-Apr-23
532508
JINDAL STAINLESS LTD.
Special Dividend
28-Apr-23
28-Apr-23
1
500249
KSB Ltd
Final Dividend
28-Apr-23
-
15
500674
Sanofi India Ltd
Final Dividend -
28-Apr-23
-
194
500674
Sanofi India Ltd
Special Dividend -
28-Apr-23
-
183
500870
CASTROL INDIA LTD.
500092
CRISIL LTD.
500180
500209
Final Dividend
04-May-23
04-May-23
3.5
Interim Dividend
04-May-23
04-May-23
7
HDFC Bank Ltd
Final Dividend
16-May-23
16-May-23
19
INFOSYS LTD.
Final Dividend
02-Jun-23
02-Jun-23
17.5
Bulk Deals (Mcap> 1000 Cr.)
Date
Security Name
Mcap
(In Cr.)
Acquirer/Seller
B/S
Quantity
Traded
Trade
Price
Value
(In Cr.)
20-Apr-23
Mastek Ltd
8,538
XTX MARKETS LLP
BUY
1,74,834
1,762
31
20-Apr-23
Mastek Ltd
8,538
QE SECURITIES
BUY
2,16,931
1,773
38
20-Apr-23
Mastek Ltd
8,538
GRAVITON RESEARCH CAPITAL LLP
BUY
4,24,081
1,767
75
BUY
3,20,955
1,771
57
20-Apr-23
Mastek Ltd
8,538
NK SECURITIES RESEARCH PRIVATE
LIMITED
20-Apr-23
Mastek Ltd
8,538
XTX MARKETS LLP
SELL
1,73,250
1,764
31
20-Apr-23
Mastek Ltd
8,538
QE SECURITIES
SELL
2,16,458
1,772
38
SELL
3,20,955
1,772
57
20-Apr-23
Mastek Ltd
8,538
NK SECURITIES RESEARCH PRIVATE
LIMITED
20-Apr-23
Mastek Ltd
8,538
GRAVITON RESEARCH CAPITAL LLP
SELL
4,24,081
1,768
75
20-Apr-23
Lux Industries Limited
6,640
GRAVITON RESEARCH CAPITAL LLP
BUY
1,88,988
1,373
26
20-Apr-23
Lux Industries Limited
6,640
GRAVITON RESEARCH CAPITAL LLP
SELL
1,88,988
1,374
26
SELL
98,859
1,917
19
20-Apr-23
Nilkamal Limited
2,938
M/S CELLO PEN & STATIONARY PVT.
LTD
20-Apr-23
Mastek Ltd
8,538
XTX MARKETS LLP
BUY
1,74,834
1,762
31
20-Apr-23
Mastek Ltd
8,538
QE SECURITIES
BUY
2,16,931
1,773
38
20-Apr-23
Mastek Ltd
8,538
GRAVITON RESEARCH CAPITAL LLP
BUY
4,24,081
1,767
75
For private circulation only
8
Trading Insights
Insight from trading volumes
Script
CMP
Total Volume
(x1000)
Monthly Avg
Volume(x1000)
% Change
CIPLA
904
4,493
2,313
94.3%
4,850
660
385
71.2%
170
16,888
11,605
45.5%
DIVISLAB
3,203
1,064
736
44.5%
AXISBANK
869
19,545
16,014
22.0%
SBIN
545
26,039
21,870
19.1%
24,254
38
32
18.1%
DRREDDY
NTPC
SHREECEM
Insight from delivery
Script
CMP
Total Delivery
Volume(x1000)
Monthly Avg Delivery
Volume(x1000)
%Change
DIVISLAB
3,203
487
209
132.9%
TATASTEEL
108
24,872
14,812
67.9%
NTPC
170
12,707
7,710
64.8%
AXISBANK
869
6,029
4,031
49.6%
BPCL
344
2,655
2,066
28.5%
1,129
738
586
26.0%
716
580
461
25.8%
SBILIFE
JSWSTEEL
*CMP-Closing Market Price
For private circulation only
9
Daily Support/ Resistance of Nifty Companies
Company
CMP
Pivot Point
R1
R2
S1
S2
NIFTY 50
17,624
17,631
17,678
17,731
17,578
17,531
ADANIPORTS
666
669
676
686
659
652
ASIANPAINT
2,844
2,836
2,859
2,874
2,821
2,798
AXISBANK
869
869
875
881
863
858
BAJAJ-AUTO
4,314
4,300
4,345
4,376
4,269
4,223
BAJAJFINSV
1,332
1,333
1,341
1,350
1,324
1,315
BAJFINANCE
5,913
5,921
5,956
6,000
5,878
5,842
BHARTIARTL
773
769
778
782
764
755
BPCL
344
343
345
347
342
340
BRITANNIA
4,256
4,274
4,301
4,346
4,229
4,202
CIPLA
904
905
911
919
898
891
COALINDIA
230
230
231
232
229
228
DIVISLAB
3,203
3,247
3,299
3,396
3,151
3,098
DRREDDY
4,850
4,862
4,904
4,958
4,808
4,767
EICHERMOT
3,247
3,259
3,297
3,347
3,208
3,170
109
109
109
110
108
108
GRASIM
1,687
1,689
1,697
1,707
1,679
1,670
HCLTECH
1,038
1,039
1,046
1,054
1,031
1,024
HDFC
2,743
2,744
2,756
2,769
2,731
2,719
HDFCBANK
1,672
1,672
1,677
1,683
1,667
1,661
530
528
534
537
525
520
2,450
2,448
2,463
2,477
2,434
2,419
GAIL
HDFCLIFE
HEROMOTOCO
HINDALCO
HINDUNILVR
ICICIBANK
430
431
434
439
427
423
2,493
2,502
2,523
2,553
2,472
2,451
894
894
899
905
889
884
INDUSINDBK
1,126
1,123
1,134
1,143
1,115
1,104
INFY
1,223
1,228
1,234
1,244
1,217
1,211
IOC
78
78
79
79
78
77
ITC
400
400
403
405
398
395
JSWSTEEL
716
718
724
731
710
705
KOTAKBANK
1,884
1,888
1,898
1,913
1,873
1,862
LT
2,233
2,235
2,250
2,266
2,218
2,203
M&M
MARUTI
NESTLEIND
NTPC
ONGC
POWERGRID
RELIANCE
SBILIFE
SBIN
SHREECEM
SUNPHARMA
TATAMOTORS
TATASTEEL
TCS
TECHM
TITAN
ULTRACEMCO
UPL
WIPRO
1,219
8,715
20,473
170
159
231
2,346
1,129
545
24,254
988
477
108
3,105
1,022
2,579
7,476
732
363
1,219
8,702
20,524
169
159
231
2,346
1,125
542
24,443
991
475
108
3,099
1,019
2,591
7,507
734
362
1,224
8,753
20,667
171
161
233
2,359
1,136
548
24,710
999
481
109
3,119
1,027
2,607
7,569
737
365
1,230
8,792
20,861
172
162
234
2,372
1,144
551
25,166
1,010
486
109
3,133
1,032
2,636
7,662
742
366
1,214
8,663
20,330
168
157
230
2,333
1,117
539
23,987
980
471
107
3,085
1,013
2,562
7,414
729
360
1,209
8,612
20,186
165
156
228
2,320
1,106
534
23,720
973
465
107
3,064
1,005
2,545
7,352
726
357
Source: Axis Direct.
For private circulation only
10
SLBM T-1 Activities
Key Highlights for 20 April (T-1):




Total Notional Volume -182Cr
Total Notional Lending Fee -0.9Cr
Top traded counter by absolute yield– LTTS X6 with an absolute yield of 2.91%
Counter with highest OI VEDANTA LTD with OI of 53 Lacs
Our Top 5 Deals for your 2nd Income (Absolute yield-Lending Fee/Share Price) Top Absolute Yield Counters
Abs. Yield till Expiry
Lending Fee in INR per share
LTTSX6
2.91%
97.8
PNBHOUSINGX6
2.64%
11
LTTSY1
2.43%
82
INDUSTOWERY1
1.45%
2
MUTHOOTFINX6
1.36%
14
Top 20 Active Counters as on 20 April (T-1):
SecurityName
L&T TECHNOLOGY
SER. LTD.
PNB HOUSING FIN
LTD.
MUTHOOT
FINANCE LIMITED
AU SMALL FINANCE
BANK LTD
POLYCAB INDIA
LIMITED
SHREE CEMENT
LIMITED
INDUS TOWERS
LIMITED
Settlement
Date
No. of
Share
Traded Value
Lendin
g fee/
share
SharePric
e
Absolute Yield
Till Expiry
Annualized
Yield
Open
Interest
Days
to
expiry
Value of
Investment
(for 100
stocks)
Expected
Value at
Maturity
01-Jun-23
8,722
8,52,703
98
3,360
2.91%
25.3%
1,71,670
42.00
3,35,960
3,45,736
01-Jun-23
15,103
1,70,055
11
427
2.64%
22.9%
47,432
42.00
42,655
43,781
01-Jun-23
1,41,431
19,95,300
14
1,039
1.36%
11.8%
3,13,686
42.00
1,03,930
1,05,341
01-Jun-23
75,780
4,55,199
6
679
0.88%
7.7%
12,23,533
42.00
67,940
68,541
01-Jun-23
15,780
4,09,660
26
3,129
0.83%
7.2%
2,17,394
42.00
3,12,920
3,15,516
01-Jun-23
200
40,000
200
24,254
0.82%
7.2%
13,240
42.00
24,25,440
24,45,440
01-Jun-23
2,15,245
1,98,735
1
138
0.67%
5.8%
10,45,379
42.00
13,770
13,862
01-Jun-23
1,158
26,616
23
3,813
0.60%
5.2%
13,309
42.00
3,81,345
3,83,643
EMAMI LIMITED
01-Jun-23
657
1,314
2
363
0.55%
4.8%
768
42.00
36,295
36,495
COFORGE LIMITED
04-May-23
150
2,875
19
3,813
0.50%
13.1%
57,683
14.00
3,81,345
3,83,262
COFORGE LIMITED
PERSISTENT
SYSTEMS LTD
LAURUS LABS
LIMITED
JUBILANT
FOODWORKS LTD
MAX FINANCIAL
SERV LTD
TATA MOTORS DVR
A ORD
SBI CARDS & PAY
SER LTD
ESCORTS KUBOTA
LIMITED
DALMIA BHARAT
LIMITED
THE RAMCO
CEMENTS LIMITED
BAJAJ AUTO
LIMITED
01-Jun-23
5,968
1,23,460
21
4,290
0.48%
4.2%
59,132
42.00
4,29,005
4,31,074
04-May-23
1,102
1,566
1
306
0.46%
12.1%
16,907
14.00
30,630
30,772
01-Jun-23
1,00,605
2,03,725
2
438
0.46%
4.0%
1,11,604
42.00
43,820
44,023
04-May-23
74
202
3
641
0.43%
11.1%
445
14.00
64,115
64,388
01-Jun-23
8,550
8,507
1
248
0.40%
3.5%
8,550
42.00
24,770
24,869
01-Jun-23
1,31,480
3,94,185
3
754
0.40%
3.5%
2,72,314
42.00
75,375
75,675
01-Jun-23
162
1,152
7
1,982
0.36%
3.1%
1,00,874
42.00
1,98,245
1,98,956
04-May-23
12
84
7
1,989
0.35%
9.2%
178
14.00
1,98,895
1,99,595
01-Jun-23
150
375
3
740
0.34%
2.9%
2,39,350
42.00
74,015
74,265
01-Jun-23
14,666
1,88,024
13
4,314
0.30%
2.6%
5,99,663
42.00
4,31,435
4,32,717
For private circulation only
11
Rollover Contracts (T-1):
Security
Series
Expiry
Shares
Traded Value
Lending Fee
Share Price
Absolute
Yield
Annualized
Yield
LTTS
Y1
04-May-23
8,019
6,53,750
82
3,360
2.43%
63.3%
INDUSTOWER
Y1
04-May-23
200
400
2
138
1.45%
37.9%
MUTHOOTFIN
Y1
04-May-23
403
5,259
13
1,039
1.26%
32.7%
SHREECEM
Y1
04-May-23
600
1,58,775
265
24,254
1.09%
28.4%
POLYCAB
Y1
04-May-23
7,675
2,54,311
33
3,129
1.06%
27.6%
AUBANK
Y1
04-May-23
53,752
3,28,008
6
679
0.90%
23.4%
JUBLFOOD
Y1
04-May-23
1,575
3,938
3
438
0.57%
14.9%
ESCORTS
Y1
04-May-23
7,630
85,439
11
1,982
0.56%
14.7%
PERSISTENT
Y1
04-May-23
500
10,000
20
4,290
0.47%
12.2%
BERGEPAINT
Y1
04-May-23
1,08,428
2,79,944
3
577
0.45%
11.7%
VEDL
Y1
04-May-23
2,64,093
3,06,084
1
280
0.41%
10.8%
RAMCOCEM
Y1
04-May-23
17,000
50,785
3
740
0.40%
10.5%
SBICARD
Y1
04-May-23
17,371
52,241
3
754
0.40%
10.4%
COFORGE
Y1
04-May-23
90
1,350
15
3,813
0.39%
10.3%
WHIRLPOOL
Y1
04-May-23
700
2,930
4
1,323
0.32%
8.2%
BAJAJ-AUTO
Y1
04-May-23
49,150
6,43,731
13
4,314
0.30%
7.9%
NAVINFLUOR
Y1
04-May-23
14,315
1,74,605
12
4,688
0.26%
6.8%
DEEPAKNTR
Y1
04-May-23
27,002
1,01,470
4
1,838
0.20%
5.3%
SLBM expiries
Sr No.
Series (A)
Series (B)
Month
1
01
X1
January
2
02
X2
February
03
03
X3
March
04
04
X4
April
05
05
X5
May
06
06
X6
June
07
07
X7
July
08
08
X8
August
09
09
X9
September
10
10
XO
October
11
11
N
November
12
12
D
December
Two separate series of contracts are made available as given below:A. Contracts which shall continueto be mandatorily foreclosed in the event of AGM/EGM
B.Contracts which shall not be foreclosed in the event of AGM/EGM.
For private circulation only
12
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
1.
2.
3.
4.
5.
6.
Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined
in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial
products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and
has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking,
the details in respect of which are available on www.axisbank.com.
ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the
Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance
business activity.
ASL has no material adverse disciplinary history as on the date of publication of this report.
I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report
accurately reflect my/our views about the subject issuer(s) or securities. I/We (Research Analyst) also certify that no part of my/our compensation
was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL or its
Associate does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial
ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report.
Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various
companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any
material conflict of interest. I/we have not served as director / officer, employee, etc. in the subject company in the last 12-month period.
ASL or its Associates has not received any compensation from the subject company in the past twelve months. I/We or ASL or its Associate has not
been engaged in market making activity for the subject company.
In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of
its associates may have:
i.
ii.
iii.
Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject
company of this research report and / or;
Managed or co-managed public offering of the securities from the subject company of this research report and / or;
Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject
company of this research report;
ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in
connection with this report.
Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly
confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in
any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate.
The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable.
Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy,
completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose
and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though
disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by
virtue of their receiving this report.
For private circulation only
13
Disclaimer:
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable
or appropriate to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report
may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial
positions and needs of specific recipient.
This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should
make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies
referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of
such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade
securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility,
financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report,
including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction
in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to
future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the
securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and
may be subject to change without notice.
ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell
the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or
other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any
recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each
other. The recipient should take this into account before interpreting this document.
ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a
result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this
report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service
transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in
this report.
Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed,
directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is
inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of
the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located
in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation
or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may
not be eligible for sale in all jurisdictions or to certain category of investors.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated
as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this
document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company
may or may not subscribe to all the views expressed therein.
Copyright in this document vests with Axis Securities Limited.
Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI – INZ000161633, ARN No. 64610, CDSL-IN-DP-CDSL-693-2013, SEBIResearch Analyst Reg. No. INH 000000297, SEBI Portfolio Manager Reg. No.- INP000000654, Main/Dealing off.- Axis Securities Ltd, Unit
No.1001, 10th Floor, Level-6, Q2 Building, Aurum, Q Parc, Plot No. 4/1, TTC, Thane – Belapur Road, Ghansoli, Navi Mumbai. – 400 710.,
Regd. off.- Axis House,8th Floor, Wadia International Centre, PandurangBudhkar Marg, Worli, Mumbai – 400 025. Compliance Officer:
AnandShaha, Email: compliance.officer@axisdirect.in, Tel No: 022-49212706
NEERAJ
CHADAWAR
For private circulation only
Digitally signed by NEERAJ
CHADAWAR
Date: 2023.04.21 08:35:15
+05'30'
14